Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

210.50p
   
  • Change Today:
    -6.00p
  • 52 Week High: 258.00p
  • 52 Week Low: 177.20p
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 1,110,630
  • Market Cap: £457.65m
  • RiskGrade: 156

Advanced Medical Solutions buys coatings firm Raleigh

By Josh White

Date: Monday 23 Nov 2020

LONDON (ShareCast) - (Sharecast News) - Surgical and wound care specialist Advanced Medical Solutions Group (AMS) has acquired independent wound care and bio-diagnostics coatings company Raleigh Adhesive Coatings for £22m in cash, it announced on Monday.


The AIM-traded firm said the acquisition would strengthen its position in the wound care sector by bringing in-house specialist services of acrylic and silicone coating, perforation processing, and some bulk materials converting capabilities, which were currently outsourced.

Silicone coating and perforation capabilities were "particularly important" to AMS, the board explained, as they are "intrinsic" to all modern advanced wound care foam dressings.

Raleigh is an existing key supplier, producing the coated adhesive mesh used in the new 'LiquiBand XL' device, which was described as an "important part" of the group's continued US growth strategy, and currently undergoing clinical trials.

In addition, Raleigh's expertise would allow the company to enter the bio-diagnostic testing sector.

The acquisition would bring "strong synergies" with AMS's finished product offering, with the opportunity to increase the efficiency of the company's wound care manufacturing operations and provide entry points into new customers and markets, cross-selling of products and services, as well as a research and development pipeline of new projects in the medical space.

AMS said the acquisition was for a total consideration of £22m in cash, payable on completion, on a debt-free and cash-free basis.

It would be funded from its existing cash resources, which totalled £67.9m at 30 June.

"We have been looking for synergistic technologies that add value to our wound care business, and this acquisition strengthens our position and product offering in that sector significantly," said chief executive officer Chris Meredith.

"Having outsourced silicone coating and perforation for some time, we are pleased to bring this capability in-house."

Meredith said Raleigh had also played an important part in improving the design of the company's LiquiBand XL mesh, which it saw as an important part of its continued US growth strategy.

"Raleigh's expertise in other sectors such as bio-diagnostic strips also opens up further new commercial opportunities for the group."

At 1239 GMT, shares in Advanced Medical Solutions Group were up 7.33% at 249p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today -6.00p
% Change -2.77 %
52 Week High 258.00p
52 Week Low 177.20p
Volume 1,110,630
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 17-May-2024

Time Volume / Share Price
16:39 51,000 @ 213.89p
16:39 51,000 @ 214.00p
16:38 50,000 @ 210.15p
16:36 75,000 @ 216.38p
16:35 65,766 @ 210.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page